Related Experiment Video
Updated: Jun 20, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
Small-molecule modulation of cellular chaperones to treat protein misfolding disorders
Lisa A Sloan1, Martin C Fillmore, Ian Churcher
1Department of Discovery Medicinal Chemistry, GlaxoSmithKline Medicines Research Centre, Stevenage, UK. Lisa.A.Sloan@gsk.com
Abstract:
The correct folding of proteins is a fundamental process in the normal physiological functioning of cells, and is mediated by cellular chaperones including members of the Hsp70 family. Many diseases are caused by a failure of cellular chaperones to adequately maintain correct protein folding, and has led to the development of a therapeutic strategy to upregulate the activity of cellular chaperones in order to ameliorate intrinsic folding deficits. A large range of pharmacological agents that can induce cellular chaperones and correct deficits associated with misfolded proteins are known. This review surveys the mechanisms and compounds that have been used to modulate cellular chaperones, and discusses the continuing challenges in translating this approach into clinical improvements in the treatment of protein misfolding disorders.
More Related Videos
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding
The...
Bacterial Protein Maturation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Export of Misfolded Proteins out of the ER

